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Oral submucous fibrosis (OSF)  is a chronic progressive, scarring, high risk pre-
cancerous condition of the oral mucosa seen primarily on the Indian sub continent and in 
South east Asia1.  The disease was first reported in 1952 by Schwartz and in 1953, Joshi 
redesignated the condition as Oral Submucous Fibrosis, implying predominantly its 
histological nature2. The condition is characterized by mucosal rigidity of varying 
intensity due to fibroelastic changes in juxta epithelial layer, reduction in vasculature and 
epithelial atrophy resulting in a progressive inability to open the mouth.3    
The precancerous nature of OSF was first postulated by Paymaster, (1955) who 
described the development of a slow growing squamous cell carcinoma in one third of 
OSMF cases.4The malignant transformation rate of 7.6% have been reported from Indian 
sub-continent over a period of 17 years.5  
According to WHO, oral squamous cell carcinoma (OSCC) in males in 
developing countries, is the sixth most common cancer after lung, prostate, colorectal, 
stomach and bladder cancer. While in females it is the tenth most common site of cancer 
after breast, colorectal, lung, stomach, uterus, bladder and liver. (2006)6 
The pathogenesis of OSF is multi factorial. The predisposing factors include areca 
nut chewing, genetic and immunologic process and nutritional deficiencies.  Areca nut is 
the main etiologic agent for OSF.7 
Nuclear factor kappa B (NF-κB) is a collective name for inducible, dimeric, 
ubiquitous transcription factors.  They are made up of members of the Rel family and 
upon cell stimulation they are transferred from cytoplasm to nucleus.  NF- κB was first 
identified as a regulator of expression of the kappa light chain gene in murine B-
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lymphocytes, but has subsequently been found in many different cells.  They play a 
crucial role in immune and inflammatory responses by regulating the genes encoding pro- 
inflammatory cytokines, chemokines and growth factors.8 
NF-κB plays a role in the pathogenesis of many inflammatory conditions such as 
rheumatoid arthritis, asthma, and inflammatory bowel disease. NF-κB can also act as an 
amplifying mechanism that exaggerates disease specific inflammatory processes through 
coordinated activation of several genes involved in inflammation9. Persistent tissue 
inflammation plays an important role in the pathogenesis of tissue fibrosis and increases 
the risk of cancer development10. Many carcinogens including areca nut and various 
oncogenic events contribute to progressive increase in NF kappa B activation which leads 
to tumor cell proliferation, migration and angiogenesis.11    The expression of NF kappa 
B proteins in pre malignant conditions such as OSF has the potential to be used as a 
marker for malignant transformation. 
The present study was done to evaluate the expression of NF-κB in formalin fixed 
paraffin embedded tissues of normal buccal mucosa, oral submucous fibrosis and oral 
squamous cell carcinoma. 
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Aims and Objectives 
 
• To evaluate the expression of NF - κB in formalin fixed paraffin 
embedded tissues of oral squamous cell carcinoma by 
immunohistochemistry. 
• To evaluate the expression of NF- κB in formalin fixed paraffin embedded 
tissue of OSF by immunohistochemistry 
• To evaluate the expression of NF- κB in formalin fixed paraffin embedded 
tissue of normal buccal mucosa by immunohistochemistry 
• To compare the expression of  NF- κB in oral squamous cell carcinoma, 
oral submucous fibrosis and normal buccal mucosa,  
 
Hypothesis 
 
 There is altered expression of NF- κB in oral submucous fibrosis and oral 
squamous cell carcinoma when compared with normal buccal mucosa. 
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Study setting 
• The study was conducted in Department of Oral and Maxillofacial Pathology, 
Ragas Dental College and Hospital, Chennai, using paraffin embedded tissues. 
 
A cross-sectional study was done to evaluate the expression of NF-κB in oral squamous 
cell carcinoma, oral submucous fibrosis and normal buccal mucosa using 
immunohistochemistry in formalin fixed, paraffin embedded tissue specimens. 
 
Study sample size 
The study material comprised of 40 formalin-fixed, paraffin embedded tissue 
specimens (archival blocks). 
 
• 20 histopathologically confirmed oral submucous fibrosis tissue specimens.  
• 10 histopathologically confirmed oral squamous cell carcinoma tissue specimens. 
• 10 normal buccal mucosa tissues specimens. 
 
Study subject 
The study comprised of 3 groups: 
Group I – (CASES) (Fig. 3)          
• 10 patients of oral squamous cell carcinoma, diagnosed clinically and confirmed 
histopathologically, were selected. 
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• Inclusion Criteria- 
Clinical: 
• A non-healing ulcerated lesion with indurated base or exophytic, fungating or 
papillary growth was considered as OSCC.  
Histopathological  
• Characterized by invasive islands and cords of malignant squamous epithelial cells in 
the connective tissue. 
Group II- (CASES) (Fig. 4) 
• 20 patients of OSF, diagnosed clinically and confirmed histopathologically, were 
selected. 
Inclusion Criteria 
Clinical: 
•    Habit of chewing areca nut in some form. 
•    The presence of fibrous bands in the labial and/ or buccal mucosa. 
•    Loss of elasticity of the buccal/ labial mucosa. 
•    Restriction of mouth opening. 
Histopathological: 
• Juxtaepithelial hyalinization. 
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• Submucosal dense and vascular collagenous connective tissue. 
• Epithelial atrophy 
• Variable number of chronic inflammatory cells 
Group III- (CONTROLS) 
• 10 patients who had clinically normal buccal mucosa, reporting to the outpatient 
department of oral and maxillofacial surgery for removal of impacted third molar 
constituted the control group. 
Inclusion Criteria 
• They had no habit of smoking, alcohol consumption or chewing areca nut. 
• They were apparently healthy with no systemic disorders. 
• They were not on any medications for systemic diseases like hypertension, diabetes. 
Methodology 
1. A detailed case history including age, sex, and occupation, past medical & dental 
history, history of habits, drugs and trauma were recorded. 
2. General examination and intra oral examination was done. 
3. Biopsy was done in both cases and controls. 
4. The tissue taken was immediately transferred to 10 % buffered formalin. 
5. After adequate fixation, tissues were embedded in paraffin. 
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6. From the paraffin embedded blocks 4 micron thick, sections were cut and used                                     
    for routine hematoxylin and eosin (H & E) staining and immunohistochemical              
    (IHC) staining. 
7. This project was approved by Institutional Review Board (IRB) of Ragas Dental  
    College and Hospital, Chennai and patient consent was taken. 
HEMATOXYLIN & EOSIN STAINING 
Reagents 
• Harri’s hematoxylin 
• 1% acid alcohol 
• Eosin 
Procedure 
• The slides were dewaxed in xylene and hydrated through graded alcohol to water. 
• The sections on the slides were flooded with Harri’s hematoxylin for 5 minutes. 
• The slides were washed in running tap water for 5 minutes. 
• The slides were differentiated in 1% acid alcohol for 5 minutes. 
• The slides were washed well in running tap water for 5 minutes. 
• The tissue sections on the slides were then stained in eosin for 30 seconds. 
• The slides were washed in running tap water for 1 minute. 
8 
 
• The slides were then dehydrated through alcohol, cleared, mounted and viewed 
under light microscope (LM). 
IMMUNOHISTOCHEMISTRY (IHC) 
Armamentarium (Fig. 1) 
• Microtome 
• Autoclave 
• Hot air oven 
• Slide warmer 
• Couplin jars 
• Measuring jar 
• Weighing machine 
• APES coated slides 
• Slide carrier 
• Aluminium foil 
• Micro-pipettes 
• Toothed forceps 
• Electronic timer 
• Beakers 
• Rectangular steel tray with glass rods 
• Sterile gauze 
• Cover-slips 
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• Light microscope 
Reagents used 
1. Conc. HCl 
2. Laxbro soln 
3. APES (3 amino propyl tri ethoxy silane) 
4. Acetone 
5. Citrate buffer 
6. Phospho Buffer Saline (PBS) 
7. 3% H2O2 
8. Deionized distilled water 
9. Haematoxylin 
10. Absolute alcohol 
11. Xylene 
Antibodies used (Fig. 2) 
1. Primary antibody – Rabbit polyclonal antibody (SantaCruz) (Clone: sc-114) 
2. Secondary antibody – Rabbit Avidin Biotin Complex staining system (SantaCruz). 
10 
 
IHC Procedure 
Pretreatment of the slides 
• The slides were first washed in tap water for few minutes 
• The slides were then soaked in detergent solution for 1 hour 
• After 1 hour, each slide was brushed individually using the detergent solution and 
were transferred to distilled water. 
• The slides were washed in two changes of distilled water. 
• The slides were washed in autoclaved distilled water. 
• The slides were immersed in 1 N HCL (100 ml HCl in 900 ml distilled water)     
overnight. 
• The following day slides were taken out of acid and washed in two changes of 
autoclaved distilled water. 
• All the slides were then transferred to slide trays, wrapped in aluminium foil and 
baked in hot air oven for 4 hours at 180 degrees centigrade. 
APES (3 Amino propyl tri ethoxy silane) coating 
Slides first dipped in couplin jar containing acetone for 2 minutes 
Dipped in APES for 5 minutes 
Dipped in two changes of distilled water for 2 minutes each 
Slides left to dry 
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Preparation of paraffin sections 
After the slides were dry, tissue section of 4 micron thickness were made in a rotary 
manual microtome. The ribbons of tissue section were transferred onto the APES coated 
slide from the tissue float bath such that two tissue bits come on to the slide with a gap in 
between. One of the tissue sections was labeled positive (P) and the other negative (N). 
Procedure 
The slides with tissue sections were treated with three changes of xylene to remove 
paraffin wax. They were put in descending grades of alcohol and then rehydrated with 
water. Slides were then treated with 3% hydrogen peroxide for 30 minutes to quench 
endogenous peroxidase activity of cells that would otherwise result in non – specific 
staining. Then the slides were transferred to citrate buffer and autoclaved for antigen 
retrieval at 15 lbs pressure for 30 minutes. Then the slides were dipped in 3 changes of 
distilled water for 5 minutes each. Circles were drawn around the tissues, so that the 
antibodies added later on do not spread and are restricted to the circle. The tissues were 
incubated in protein blocking serum for one hour in an enclosed hydrated container. Then 
the slides were wiped carefully without touching the tissue section to remove excess of 
blocking serum. The primary antibody, rabbit polyclonal antibody, 1:50 dilution was 
added to P tissue on the slide and then to the N, PBS was added. The slides were 
incubated for one hour. Then the slides were wiped carefully without touching the tissue 
section to remove excess of antibody and washed with three changes of cold PBS for 5 
minutes. Then a drop of biotin conjugated secondary antibody was added on both the 
sections and the slides were incubated for 30 minutes. Later slides were washed in three 
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changes of cold PBS for 5 minutes in each. The slides were wiped carefully without 
touching the tissue section to remove excess PBS. Then a drop of avidin biotin enzyme 
reagent was added on both the sections and the slides were incubated for 30 minutes. The 
sections were washed in 3 changes of cold PBS for 5 minutes in each. Then the slides 
were wiped carefully without touching the tissue section to remove excess PBS. Then a 
drop of freshly prepared DAB (3’ – Diaminobenzidine Tetra Hydrochloride – a substrate 
chromogen) was added on both sections. Slides were then washed in distilled water to 
remove excess DAB and counter stained with hematoxylin. The slides were placed in a 
tray with tap water for bluing. Then the slides were transferred to 70% alcohol, 100% 
alcohol and one change of xylene. The tissue sections were mounted with DPX. The 
slides were then observed under the microscope. Throughout the procedure care was 
taken not to dry the tissues. 
Positive Control 
A known case of oral squamous cell carcinoma specimen tissue were fixed, processed, 
embedded, sectioned and stained in same manner and used as positive control. One 
positive control tissue slide was included for each batch of staining. 
 
IHC PROCEDURE FLOW CHART 
APES coated slides with 2 paraffin embedded tissues 
Placed in xylene thrice (5 minutes each) 
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Placed in 100% isopropanol (5 minutes) 
Placed in 70% isopropanol (5 minutes) 
Washed in distilled water thrice (5 minutes each) 
Placed in 3% hydrogen peroxide (20 minutes) 
Kept in citrate buffer at pH 6 and autoclaved for antigen retrieval and bench cooled   
for40 minutes 
Washed in distilled water thrice (5 minutes) 
Protein blocking serum added and incubated for one hour  
Primary antibody added to the specimen and incubated for one hour 
Washed in PBS thrice (5 minutes each) 
Secondary antibody added and incubated in an enclosed hydrated container (30 minutes) 
Washed in PBS thrice (5 minutes each)  
avidin biotin enzyme reagent added and incubated (30 minutes)  
Washed in PBS thrice (5 minutes each) 
DAB added and incubated in an enclosed hydrated container (5 minutes) 
Washed in PBS thrice (5 minutes each) 
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Stained with haematoxylin (20 seconds) 
Washed in tap water 
Placed in 70% isopropanol (1 minute) 
Placed in 90% isopropanol (1 minute) 
Placed in 100% isopropanol (1 minute) 
Placed in xylene (1 dip) 
Slides were mounted using DPX 
Slides were observed under the LM and graded 
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Criteria for evaluation of NF-κ B staining 
The following parameters were used to evaluate NF-κ B staining 
1. Tissue localization of stain – NF-κ B staining was present either present in the 
epithelium/connective tissue or was present in both. Localization in basal layer or 
suprabasal layer of the epithelium was assessed.  
2. Cellular localization of stain – Nucleus and /or cytoplasm 
3. Intensity of the stain – Each positive case was graded as no stain (0), mild (+), 
moderate (++), and intense (+++). 
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Statistical analysis was done using SPSS TM software (version 11.5).  p value less than 
0.05 was considered to be statistically significant. 
 
• Pearson’s Chi-square test was done to compare mean age, the distribution of gender 
and  habits,  tissue localization of stain, cellular location, nature of stain, intensity of 
      stain and the percentage of cells stained among the three study groups. 
 
• The inter-observer variability for the intensity of stain and percentage of cells stained 
was assessed using kappa statistics. 
 
• To compare the mean labeling index between the groups, Mann Whitney U test was 
used. 
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NF – κB – STRUCTURE AND FUNCTIONS 
 
 The transcription factor NF - κB was first discovered in 1986 by David Baltimore 
and Ranjan Sen as a factor in nucleus that binds the promoter of the kappa chain of 
immunoglobulin in B cells12. NF- κB transcription factor include a collection of proteins 
with functions conserved from the fruit fly, Drosophila melanogaster to humans. Among 
the commonly used model organisms, these transcription factors are absent in yeast and 
Caenorhabditis elegans13. NF - κB is a collective name for ubiquitous inducible dimeric 
transcription factors that are made up of members of the Rel family of DNA binding 
proteins that recognize a common sequence motif 8.  
Mammals express five NF- κB proteins that belong to two sub – families 8: 
 
- NF – κB proteins.  
- Rel proteins.  
 
 
 All these proteins share a highly conserved DNA- binding / dimerization domain 
called the Rel Homology Domain (RHD) 14. Members of NF- κB sub family include 
p105, p100 and Drosophilia Relish. They are encoded by NF- κB 1 and NF – κB2 genes, 
whose products are first synthesized as large precursors p105 and p100 respectively that 
require proteolysis processing to produce the mature p50 and p52 NF – κB proteins 8. 
They contain long C- terminal domains that contain multiple copies of ankyrin repeats 
which act to inhibit these proteins. These members are not activators of transcription 
except when they form dimers with members of the Rel subfamily 13.  
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The Rel sub family includes c-Rel, RelB, Rel A (p65), Drosophilia dorsal and Dif. 
They are synthesized as mature products and do not require proteolytic processing. They 
contain C- terminal transcription activation domains, which are not conserved at the 
sequence level across species 13.  
NF- κB family proteins can form homodimers or heterodimers in vivo except for 
Rel B which can only form heterodimers  in vivo14.  
 
PATHWAYS OF NF- κB 
 
There are two pathways that lead to the activation of NF- κB.  
 
Canonical / Classical pathway.  
Non – canonical / alternate pathway15.  
 
 In canonical pathway, NF- κB dimers such as p50/ Rel A are maintained in the 
cytoplasm by inhibitor of NF- κB (IκB). Activation of IκB kinase (IKK) complex i.e. 
(IκBα, IκB β and IκBγ) leads to the phosphorylation of IκB α, which leads to 
ubiquitination and degradation by proteosome. NF-κB then enters the nucleus to turn on 
target genes 16. In this pathway, one of the target gene activated by NF- κB is that which 
encodes IκBα. The newly synthesized IκBα   can enter the nucleus, remove NF-κB from 
DNA, and the complex can come back to the cytoplasm 13. The activation of classical 
pathway is essential for innate immunity and also for inhibition of apoptosis 17.  
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In the non canonical pathway, p100/ Rel B Complex are activated. Here the IKK 
complex does not contain IκBγ or NEMO. Activation of NF – κB inducing Kinase 
(NIK) cause phosphorylation of IκBα; which in turn phosphorylates p100 / Rel B. This 
cause proteolysis of p100 to P52 and liberation of p52 / Rel B complex occurs into the 
nucleus. The NF – κB enters the nucleus and activate target genes 15. This pathway is 
important for the development of secondary lymphoid organs and adaptive immune 
response 17.  
 
ACTIVATORS AND TARGET GENES FOR NF – κB 
 
Many stimuli can rapidly activate NF – κB, such as stress induced stimuli, e.g.: 
Reactive oxygen intermediates (ROI) and ultraviolet light.  Other stimuli include 
bacterial and viral infections and their products such as lipopolysaccharide and double-
stranded RNA 18.   
The various target genes for NF – κB include cytokines which activate the 
immune cells. The cell adhesion molecules such as V- CAM, E - CAM are needed for 
cell migration and repair.  NF – κB also activates the acute phase response proteins 
during inflammation.  NF- κB regulates transcription of genes involved in 
immunoregulation, inflammation, growth regulation, carcinogenesis and apoptosis19, 20.  
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INHIBITORS OF NF – κB 
 
 NF – κB binds to 9 - 10 base pair DNA sites (κB sites) as dimers18. The activity 
of NF - κB is primarily regulated by interaction with inhibitory IκB proteins. The IκB 
are characterized by the presence of multiple ankyrin repeats and interact with NF- κB 
via RHD8. The RHD serves several functions; this domain can act as the dimerization and 
DNA binding domain of this class of proteins as it contains nuclear localization sequence 
and it is the site for binding of IκB21, 22. 
IKK complex is composed of three subunits IκBα IκBβ and IκBγ (also known as 
NF- κB essential modulator (NEMO) 23. In most cells, NF-κB is present as a latent, 
inactive IκB – bound complex in the cytoplasm18. The stimulation by different pathogens 
and other inducers include viruses. Cytokines lead to the activation of signaling cascades 
that activates the IκB complex and causes phosphorylation of IκB. The NF – κB is then 
released and translocated to the nucleus where they bind with target genes and regulate 
their transcription24.  
 
FUNCTIONS OF NF – κB 
 
NF – κB in Immune system 
NF – κB is required for the normal functioning of the immune system. Cytokines 
and their corresponding receptors are key mediators of the immune system that are 
crucial for immune cell communication and effector functions during an active immune 
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response25. Studies on c-rel-deficient mice have demonstrated that c-rel is essential for 
IL-2, IL-3, expression in T lymphocytes, and IL-6 expression in B cells and TNF-α 
expression in macrophages and IL-12 expression in dendritic cells26, 27, 28. 
 Mice deficient in the NF- κB2 gene mainly have defects in lymph node and 
splenic architecture, although development is normal. This leads to antigen presentation 
impairment from accessory cells such as dendritic cells and macrophages but does not 
affect B or T cells directly. All these studies emphasize the significance of NF – κB in 
normal development and functioning of the immune system29, 30. 
  
NF- κB activation is needed for haematopoiesis. 
NF- κB is required for the development and function of B cells, T cells, 
thymocytes, dendritic cells, macrophages and fibroblasts31. Deletion of both p50 and p52 
affects further maturation of committed progenitors of the lymphoid and osteoclast 
lineages32, 33. NF- κB/Rel plays a role in myeloid differentiation, as deletion of both p65 
and c-Rel affects early common myeloid progenitors, leading to reduced colony forming 
unit progenitors, impaired erythropoiesis, aberrant expansion of granulocytes, and 
macrophage apoptosis34.  
In innate immunity, NF – κB is activated by various pathogens, which leads to 
microbicidal mechanisms of macrophages; production of inflammatory cytokines such as 
IL – 12 and activation of NK cells to produce IFN – γ. In adaptive immunity, IL – 1 
family of proteins activate NF – κB, which results in T – helper cell responses8.  
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NF – κB in Apoptosis 
 
There are different activation pathways of NF- κB that cause expression of 
proteins which promotes apoptosis or inhibits apoptosis. This depends on the cell type or 
the type stimulation that determines which signaling pathways are activated. In most 
cells, NF- κB activation protects the cell from apoptosis through induction of genes such 
as TNF receptor associated factor 1 (TRAF 1), Bcl – XL35. NF-κB activation more 
commonly counteracts p53 induced apoptosis by destabilizing p53 via enhanced Mdm2 
expression36. But recent studies show that NF – κB has a pro-apoptotic role, by inducing 
FasL expression37. Another possible pro-apoptotic mechanism involves p100 mediated 
transcription independent cell death through activation of caspase -836.  It plays an 
essential role in activation of wild type p53 to initiate pre-apoptotic signaling in response 
to ROS accumulation38. 
 
Role of NF – κB in inflammatory disease  
 
In chronic inflammatory disease, NF – κB increases the expression of genes for 
many cytokines and adhesion molecules.  One such gene is that for inducible nitric oxide 
synthase which is increased in airway epithelial cells and macrophages in patients with 
asthma and in synovial cells in inflamed joints 8, 39, 40. Cytokines including IL – 1β and 
TNF α can also activate the NF – κB pathway, which can result in amplification of 
inflammatory response and the persistence of chronic inflammation at local sites41.  
23 
 
These metabolites contribute to the pathogenesis of inflammatory process. Although NF 
– κB acts as an initiator of inflammation, recent studies suggest that it is also involved in 
the resolution of inflammation42.  In certain conditions during the resolution phase, NF – 
κB prolong rather than inhibit the inflammation, delaying tissue repair43. 
During onset of inflammation, NF – κB stimulation leads to p65 – p50 induced 
pro-inflammatory gene expression whereas during resolution, translocation of p50 – p50 
homodimers is induced.  This p50 homodimers can down regulate anti - apoptotic gene 
expression, but they cannot activate gene expression on its own.   This p50 homodimers 
along with other co-factors can activate pro-apoptotic genes.  The pro – inflammatory 
cells will receive apoptotic stimuli, and will be phagocytosed by macrophages which 
have a role in resolution of inflammation10. 
 
Role of NF – κB in cancer 
 
 
 NF – κB plays an important role in regulation of apoptosis.  It suppresses 
apoptosis by regulating anti-apoptotic proteins such as inhibitor of apoptosis proteins 
(IAP), TNF receptor associated factor 1 (TRAF 1) and Bcl - XL.   NF – κB also blocks 
apoptosis by inhibiting Jun N-terminal kinase (JNK) pathway and accumulation of 
reactive oxygen species17.   
NF – κB plays an important role in invasion and angiogenesis of tumor cells by 
regulating matrix metalloproteinase 2 and 9, serine protease urokinase – type 
plasminogen activator (uPA).The production of angiogenic factors such as IL- 8, TNF, 
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VEGF produced by macrophages, neutrophils are regulated by NF – κB activation44.     
NF – κB promotes cell cycle progression by regulating the expression of gene involved 
in cell cycle such as cyclin D1, D2, D3 E and c- myc. 
 
 The earliest evidence for the role of NF- κB in oncogenic transformation was 
derived from the fact that v - Rel, a highly oncogenic retroviral homologue of c – Rel 
leads to carcinogenesis of avian lymphoid cells41,45. Later studies suggested that v – Rel 
has the capacity of transforming mammalian cells in vivo.  Constitutive activation of NF 
– κB contributes to the malignant progression in major forms of human cancer such as 
breast cancer, esophageal cancer, Barrett’s esophagus, head and neck squamous cell 
carcinoma, hepatocellular carcinoma, multiple myeloma, oral squamous cells carcinoma 
and prostate cancer20.  
 
 Different abnormalities in the regulation of NF – κB pathway are seen in human 
malignancies.  These changes are due to alterations in regulatory proteins that activate 
signaling pathways of NF – κB and in constitutive presence in the nucleus.  In some 
tumors, mutations that inactivate the IκB proteins and amplification, rearrangements of 
genes encoding NF – κB family members or abnormalities that are seen in NF – κB 
pathway are seen. Constitutive activation of NF – κB pathway can lead to resistance to 
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tumor cell killing by chemotherapy and radiation therapy by enhanced expression of anti 
– apoptotic genes41. 
 NF – κB regulates many genes that are involved in carcinogenesis such as in 
inflammation it is through upregulation of TNF, IL -1, Chemokines NF – κB activation 
promotes cell survival through increased expression of COX2, iNOS, MMP-9, uPA. The 
anti – apoptotic genes regulated by NF – κB are bcl – xl, TRAF.  NF – κB regulates the 
genes involved in tumor cell invasion and metastasis through upregulation of VEGF, 
TNF, IL-1, IL-8, ICAM -1, VCAM -1, ECAM -1.46 
 
Links between NF - κB, inflammation and Carcinogens in the development of 
cancer 
 
 Many chemical and physical carcinogens implicated in the promotion of human 
cancer activate NF – κB.   Nicotine and carcinogens in tobacco and betel nut are 
associated in the pathogenesis of head and neck malignancies11. Chemotherapy and 
radiation induced DNA damages activates NF – κB through signaling mechanism of IKK 
complex. 
In inflammation associated cancer, non-genetic stimuli encourage the survival and 
proliferation of cells.  NF – κB has dual actions in tumor promotion; first by preventing 
the death of cells with malignant potential and second by stimulating the production of 
pro-inflammatory cytokines in inflammatory cells in tumor mass.  These cytokines then 
signals the cell to promote their survival and proliferation47.  
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Classical NF – κB pathway i.e. the IKK – β dependent NF – κB activation 
pathway might show the molecular link between inflammation and tumor promotion.  
Mouse studies of inflammation associated liver and colon cancer supports this 
hypothesis48, 49.   
 So, in chronic inflammatory diseases, pro-inflammatory factors cause 
accumulating of DNA damage in dormant pre-malignant cells in tumor 
microenvironment to become malignant.  NF – κB activation in these pre-malignant cells 
prevents apoptosis of these cells and enables tumor growth10.  
 
NF – κB IN PRE-CANCER AND ORAL CANCER 
 
 
Frank G Ondrey, Gang Dong, John Sunwoo, Zhong Chen (1999)50 
 
 In this study, they examined the activation, composition and function of 
transcription factors in HNSCC cell lines that express pro-inflammatory cytokines by 
using electrophoretic mobility shift and reporter gene assay. Constitutive activation of NF 
– κB, Activated protein – 1 (AP – 1) and NF – IL6 DNA binding proteins was detected. 
Supershift analysis with antibodies specific for NF – κB showed that the NF – κB 
binding protein included p65– p50. Mutational analysis of NF – κB in the IL – 8 promoter 
region showed that constitutive IL – 8 reporter activity in HNSCC. So they concluded  
that NF – κB, AP – 1 and NF – IL6 promote the expression of pro-inflammatory & pro-
angiogenic cytokines IL – 8 in HNSCC.  
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Nakayama H, Ikebe T, Beppu M   et al (2001)51 
 
 The authors used immunohistochemistry to examine the expression of NF – κB 
and the signaling molecules leading to NF – κB activation in 36 untreated biopsy 
specimens from patients with squamous cells carcinoma (SCC) and in 15 specimens from 
patients with epithelial dysplasia of oral cavity.  NF – κB (p65) and IκB α wtre 
expressed highly in all SCC specimens.  The normal squamous epithelia and epithelial 
dysplasia were negative.  The results suggest that high expression levels of p65 and IkB α 
contribute to malignant behavior and antiapoptotic activity in SCC of oral squamous 
epithelium. 
 
Tamatani T, Azuma M, Bando T et al (2001)52 
 
 The authors examined the expression levels of proteins related to NF – κB 
activation and IκK activity in head and neck cancer cells and also in normal oral 
epithelium and salivary gland cells.  They had shown that enhanced NF – κB activity is 
caused by the phosphorylation and degradation of IκB α protein.  There was no 
significant difference in the expression levels of IκK β or IκK γ in cancer lines, 
compared to those in normal cells, but increased expression of IκK α protein was 
observed in cancer cells.  These results suggest that enhanced NF – κB activity in head 
and neck cancer cells is due to IκK activity. 
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Nelson L. Rhodus, Vu Ho, Craig S Miller, Sandra Myers, Frank Ondrey (2005)53 
 
 The aim of this pilot study was to determine the level of NF – κB dependent 
cytokines in whole unstimulated saliva in subjects with oral premalignant lesions 
(OPML) as compared to those with squamous cell carcinoma (SCC).  A sample size of 13 
was taken in each group. The cytokines analysed were TNF – α, interleukin – 1, 6 and 8. 
The saliva samples were centrifuged and cytokine analysis was performed on the 
supernatants by ELISA. This study showed that these cytokines were elevated in saliva of 
OSCC and OPML when compared with normal. The cytokines with pro-inflammatory 
and pro-angiogenic activity are produced by SCC and they contribute to the progression 
of the disease. NF – κB is elevated in subjects with tobacco use and chronic 
inflammatory condition and it is associated with the expression of pro-inflammatory and 
pro-angiogenic cytokines such as IL – 1, IL – 6 and IL – 8. This study was done to test 
the hypothesis that in presence of chronic inflammation, irritation NF – κB will be 
elevated leading to the activation of pro-inflammatory, pro-angiogenic cytokines which is 
associated with progression of pro-malignant lesions to SCC. 
 
Ni W F, Tsai C H, Yang S F, Chang Y C et al (2006)54 
 
In this study, normal buccal mucosa and oral submucous fibrosis (OSF) were used 
to compare NF – κB expression.  Seventeen OSF and six normal buccal mucosa 
specimens were examined by IHC.  Primary human buccal mucosa fibroblasts were 
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established and challenged with safrole; a compound seen in Piper betel.  NF – κB 
expression was significantly higher in OSF specimens and expressed mainly by 
fibroblasts, endothelial cells and inflammatory cells.  Chewing areca quid may activate 
NF – κB expression that may be involved in pathogenesis of OSF. 
 
Alok Mishra, Alok Bharti, Bhuder C Das (2006)55 
 
 In this study, they have analyzed the activation of NF – κB and its alterations, in 
the expression of different NF – κB proteins during oral carcinogenesis in vivo using 
tissue biopsies from precancerous and cancerous oral lesions.  And also the role of high 
risk human papilloma virus (HPV – 16) which activates the p 50 / p65 NF – κB complex 
formation, which promotes differentiation of oral neoplastic cells led to better prognosis 
of the oral cancer. In this study, biopsy specimens were 110, n = 10 (normal) oral 
precancer (n = 34) and cancer n= 66. 
Expression of p50 protein was 1000 in all the normal tissues and 40% of 
precancerous lesion & 70% of oral cancers showed moderate to high expression of NF – 
κB. 
 
Bindhu O S, Ramadas K, Pillai M R et al (2006)56 
 
 The study investigated the pattern of expression and activity of gelatinases (MMP 
2 and MMP 9) among the histologic groups of oral tissues such as normal oral tissues, 
leukoplakia and invasive oral carcinoma.  The study also aimed at the role of NF – kB 
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and their inhibitor protein, IκB in all these group of tissues.  137 subjects were examined 
for the gelatinolytic activity assay for NF – κB (p50, p65) and IκB.  High expression 
levels of p65 and IκB have shown to contribute to malignant behavior and anti-apoptotic 
activity in SCC of oral squamous epithelium.  These observations suggest the regulatory 
role of NF – κB on the expression of gelatinases, and thereby in malignant 
transformation. 
 
Chung H C, Parker S J, Carter J et al (2006)57 
 
 This study determined the feasibility of micro array gene expression analysis of 
formalin fixed tissue, and compared with gene expression of independent frozen tumor.  
This gene list which is highly predictive of recurrence free survival is a prognostic 
biomarker.  These gene sets are involved in epithelial – mesenchymal transition, NF – κB 
activation and cell – adhesion, which are enriched in high risk tumors. This study 
provides the gene expression analysis to distinguish patients who are at high risk of 
recurrence. 
 
Santhi W S, Sebastian P, Pillai M R et al (2006)58 
 
 This study investigated the role of NF – κB and COX – 2 in oral cancer 
progression and assessment of minimal residual disease (MRD).  Expression of NF – κB 
and IκB was evaluated using IHC, while RT – PCR was used to detect COX – 2 
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expression.The present study demonstrated that nuclear localization of NF – κB and IκB 
protein was increased with histological progression from normal to cancer tissue.  This 
study also suggests an association between NF – κB activation and over expression of 
COX – 2 in oral cancer.  NF – κB expression had a negative correlation in the evaluation 
of surgical margins, both p50 and   p65 had a decreasing cytoplasmic expression from 
tumor to surgical margin to extra marginal tissue when evaluated by IHC.  These markers 
are useful in predicting oral tumorigenesis and also for detection of MRD. 
 
Sharma Chhavi, Kaur Jatinder, Aggarwal B B et al (2006)59 
 
 This study was designed to test the hypothesis that curcumin may inhibit the 
activation of NF – κB in smokeless tobacco exposed oral premalignant and cancer cells.  
Smokeless tobacco extract induced NF – κB activity was inhibited by curcumin in oral 
premalignant and cancer cells in vivo.  Thus, curcumin can be used as chemo preventive 
agents in Leukoplakia & OSCC. 
 
Meenakshi Sawhney, Nidhi Rohatgi, Aggarwal etal (2007)60 
 
 In this study, they analyzed the expression of NF – κB and COX -2 in oral tissues 
in hyperplastic, dysplastic lesions and also in OSCC by IHC and correlated with tobacco 
habits.  Immunohistochemical analysis of p65 NF-κB protein was done in 15 normal 
tissues, 78 OPLs and 107 OSCC. In normal, 73% showed no cytoplasmic immune 
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reactivity while 26% showed mild NF – κB immune re activity.   In precancerous 
lesions, 68% showed immune reactivity 58% of tumors showed p65 expression.  The 
significant increase in expression of NF – κB & COX -2 from normal to OPL to OSCC 
suggest their association with development and progression of oral cancer.  Among the 
ST products khaini consumption is association with NF – κB over expression in both 
OPL’s and OSCC. 
 
NF -kB in other Cancers 
 
Cogswell C P, Guttridge D C, Baldwin Jr.  S et al (2000)61 
 
 In this study, human breast cancer and adjacent normal tissue were analyzed by 
gel mobility shift assay and IHC for activation of NF-κB. The NF-κB genes   were found 
to be elevated in breast tumors indicating functional NF – κB activity. 
 
NairA, Venkatraman M, Maliekal T   et al (2003)62 
 
 In this study immunohistochemical analysis was done using 106 paraffin 
embedded cervical tissue specimen of different histological grade.  In normal cervical 
tissue & low grade squamous intra epithelial lesions, p50-Rel A were localized in 
cytosol, whereas in high grade squamous cell carcinoma of cervix,  p50 – Rel A was seen 
in nucleus.  Immunohistochemical analysis revealed that phosphorylation of IκB- α 
occurs in squamous intra epithelial lesions, showing that it is degraded as tumor progress. 
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This study concluded that NF – κB activity is increased during cervical cancer 
progression. 
 
Ismail H A, Lessard L, Saad F et al (2004)63 
 
 The aim of this study was to assess NF – κB expression in lymph node metastases 
of prostate cancer.  54 prostate cancer patients were analyzed of which 32 had lymph 
node metastases and 22 had no metastases.  Nuclear localization of NF–κB was greater 
in metastatic lymph node when compared to controls, suggesting that NF – κB is 
upregulated in prostate cancer lymph node metastasis. 
 
Ma J, Zhang Z, Xu S et al (2008)64 
 
 In this study, Tunel method was used to investigate the clinical significance of NF 
– κB on apoptosis in non-small cell lung cancers (NSCLC).  The expression of NF – κB 
was correlated with the differentiation of NSCLC.  NF – κB inhibits apoptosis in 
NSCLC. 
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PATIENT CHARACTERISTICS: 
 
                     Ten cases of OSCC (Group I), 20 cases of OSF (Group II) and 10 cases of 
clinically appearing normal mucosa (Group III) were analyzed for immunoreactivity of  
NF –κB protein. All the samples in group I, II and III were taken from the buccal 
mucosa. 
                       The patients’ age ranged from 36 to 82 years (mean 52.5 ± 14) in group I, 
from 23 to 49 years (mean  34.3 ± 6.3) in group II and from 22 to 42 years (mean 28.7 ± 
6.5) in group III (Table 1, Graph 1).  
                        Of the 10 patients in group I, 80% (n=8) were men and 20% (n=2) were 
women. In group II all the cases were men, whereas in group III, 70% (n=7) were men 
and 30% (n=3) were women (Table 2, Graph 2).  
                         Depending upon the habits, the patients were segregated into smokers, 
chewers and the third group included smokers and chewers. In group I, 60% (n=6) of 
patients were tobacco chewers, 10% (n=1) of patients were smokers and 30% (n=3) had 
no habits. In group II, 85% (n=17) of patients were areca nut and smokeless tobacco 
chewers, 15% (n=3) of patients were chewers and smokers. None of the patients in group 
III had any smoking or chewing habits. (Table 3, Graph 3). 
                             According to the histopathological grading in OSCC, 70% (n=7) of 
patients had well differentiated OSCC, 30% (n=3) of patients had moderately 
differentiated OSCC.  
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DISTRIBUTION OF NF – κB STAINING AMONG 3 GROUPS: 
                               NF – κB revealed positivity in group I (Fig 7 & 8), II (Fig 11 & 12) 
and III (Fig 15 & 16). In Group I all the cases showed 100% staining for NF – κB, 
whereas in Group II and Group III, positive staining was observed in 85% and 60% 
respectively.  
 
Tissue localization of stain (Table 4, Graph4) 
NF – κB staining was seen both in the epithelium as well as in the connective 
tissue. Of the 10 cases examined in group I, 100% (n=10) cases showed positive staining 
in both epithelium as well as connective tissue. 70% (n=7) of the cases showed 
cytoplasmic staining whereas 30% (n=3) showed nuclear staining. The labeling index of 
these cases which expressed nuclear positivity was 22.8%, 26%, 31.8% respectively. In 
connective tissue the staining was localized to muscle fibers and endothelial cells.     
            Of the 20 cases examined in group II, 85% (n=17) cases showed positive staining 
in epithelium and connective tissue, whereas 15% (n=3) cases showed negative staining. 
Of the positive staining cases in this group 30% (n=6) showed nuclear staining while 
55% (n=11) showed cytoplasmic staining. The labeling index of the 6 cases which 
expressed  nuclear positivity were 11%, 15%, 18%, 18.9%, 19.5%, 21.3% respectively. 
In connective tissue, staining was predominantly seen in lymphocytes, muscle fibers and 
endothelial cells. 
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In group III, of the 10 cases examined 60% (n=6) showed positive staining in 
epithelium whereas 40% (n=4) showed absence of staining. Of the positive stained cases, 
50% (n=5) showed cytoplasmic staining and 10% (n=1) showed nuclear staining.  
 
INTENSITY OF STAIN:  
 
Distribution of staining intensity in the basal layer among the groups (Table 5, 
Graph 5). 
When the staining intensity of NF – κB in the basal layer was compared between the 
study groups 10% (n=1) of OSCC showed negative staining whereas, 15% (n=3) of OSF 
and 40% (n=4) of normal showed negative staining. Mild intensity of staining was seen 
in 40% (n=4) of OSCC while mild staining was seen in 30% (n=3) of normal cases, 40% 
of OSCC showed moderate staining in comparison with 30% in OSF and normal. 10% 
(n=1) of OSCC showed intense staining while there was no intense staining in normal 
cases. But the results were not statistically significant (p = 0.058) 
 
Distribution of the staining intensity in the suprabasal layer among the groups 
(Table 6, Graph 6) 
In OSCC, none of the cases showed negative staining, whereas 20% (n=4) in OSF and 
40% (n=4) in normal showed negative staining. 50% of OSCC (n=5) showed moderate 
staining when comparison with 45% (n=9) in OSF and 10% (n=1) in normal. . But the 
results were not statistically significant (p = 0.28) 
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Comparison of staining intensity in the basal layer between group II and group III 
(Table 7, Graph 7) 
 In OSF, 15% of the cases showed no staining in the basal layer while 40% had 
mild staining, 30% moderate staining, and 15% of the cases had intense staining in the 
basal layer. In normal mucosa, 40% exhibited no staining in the basal layer whereas mild 
and moderate staining was seen in 30% of the cases. None of the cases in the normal 
showed intense staining in the basal layer. But the results were not statistically significant 
(p = 0.325) 
 
Comparison of staining intensity in the suprabasal layer between group II and 
group III (Table 8, Graph 8) 
 In OSF samples, 20% did not show any staining, while 30% had mild stain, 45% 
had moderate staining, and 5 % intense staining. In the normal mucosa, 40% had no 
staining whereas mild staining was seen in 40% cases, 10% showed moderate and intense 
staining. The difference in the staining intensity in the suprabasal layer between OSF and 
normal did not show statistical significance (p=0.27) 
 
Comparison of staining intensity in suprabasal layer between group I and group III 
(Table 9, Graph 9) 
 In OSCC, mild, moderate and intense staining was seen in the suprabasal layers in 
40%, 50% and 10% of the cases respectively. In normal mucosa, 40% showed no staining 
in the suprabasal layer, while 40%, 10% and 10% of the cases exhibited mild, moderate 
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and intense staining respectively. The difference in the staining intensity in the suprabasal 
layer between OSCC and normal did not show statistical significance (p=0.08) 
 
Comparison of staining intensity between basal and suprabasal layer within the 
epithelium in Group II (Table 10, Graph 10).  
Here 100% of cases showed negative staining in both basal and suprabasal layer. 
75% of cases showed mild staining in both basal and suprabasal layer. 25% of cases 
showed mild staining in suprabasal and moderate staining in basal layer. 100% of cases 
showed moderate and intense staining in both basal and suprabasal layer. These results 
were statistically significant (p=0.000). 
 
Comparison of staining intensity between basal and suprabasal layer within the 
epithelium in Group III (Table 11, Graph 11). 
Comparison of staining intensity in normal oral mucosa showed that 75% of cases 
did not show staining in both basal and suprabasal layers. 25% of the cases showed mild 
staining in the basal layer and absence of staining in the suprabasal layer. 11.1% of the 
cases exhibited mild staining in the basal layer and moderate staining in the suprabasal 
layer. 66.7% of the cases had moderate staining in both basal and suprabasal layer. 22.2% 
of the normal cases showed intense staining in the basal and moderate staining in the 
suprabasal layer. These results were statistically significant (p=0.02). 
 
Comparison of mean labeling index among the study groups 
In OSCC, 3/10 cases showed nuclear staining and their labeling index were 
22.8%, 26%, 31.8%. In OSF, 6/20 cases showed nuclear staining which had the mean 
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labeling index as follows, 11%, 15%, 18%, 18.9%, 19.5%, 21.3%. In normal, 1/10 case 
showed nuclear staining and its labeling index is 8%.  The mean labeling index for OSCC 
22.5, OSF 21.2, and normal 17.05, but this difference was not statistically significant. 
 
Comparison of mean labeling index between Group I and Group III & Group II 
and Group III 
 
Comparison of mean labeling index between OSCC (11.65) and normal (9.35) 
was done. Similarly the mean labeling index of OSF (16.65) was compared to normal 
(13.2), but these differences were not statistically significant. 
The inter-observer agreement for the intensity of stain for all the 3 groups was 
arrived at kappa values: 0.648 and 0.5. 
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NF – κB is a transcription factor that is known to play an important role in 
controlling immune and inflammatory responses by regulating the genes encoding pro-
inflammatory cytokines, chemokines and growth factors61.  Constitutive activation of NF 
– κB contributes to the malignant progression in most of human cancers.  It suppresses 
apoptosis by regulating anti-apoptotic proteins such as inhibitor of apoptosis proteins 
(IAP), TRAF – 1, Bcl – XL and also by inhibiting JNK pathway and accumulation of 
reactive oxygen species.  It also has a promoting role in invasion and angiogenesis by 
regulating MMP 2 and MMP 944.  It regulates many genes that are involved in 
carcinogenesis such as TNF, IL – 1, COX-2, iNOS, VEGF, ICAM – 1, VCAM – 1 and 
ECAM – 146. 
 OSF is a well recognized pre-cancerous condition with a multifactorial 
pathogenesis that include consumption of chillies, nutritional deficiency, chewing of 
areca nut, genetic susceptibility, altered salivary constituents, autoimmunity and collagen 
disorders7.  Epithelial dysplasia in OSF is considered to be one of the indicators for 
predicting the potential malignant transformation of this condition. The malignant 
transformation of OSF is in the range of 7 – 13% and recently the carcinogenecity of 
areca nut without tobacco has also been identified.  Though the induction, maintenance 
and progression of fibrosis in OSF have been addressed, the mechanism inducing 
carcinogenesis in OSF is not fully understood65.  Therefore in order to predict the 
malignant potential in OSF, biomarkers could have a predictable role.   Previous studies 
indicate that alterations in the expression of biomarkers can occur in the epithelium of 
OSF.  These alterations may predispose to carcinogenesis and thus they could be used as 
surrogate markers of malignant transformation66.   
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 Since NF – κB is a transcription factor that is known to involve in growth, 
invasion and anti-apoptotic activity of cancer cells. In this study we wanted to ascertain 
its expression in OSCC and OSF and compare its activity with that of normal oral 
mucosa. 
 
PATIENT CHARACTERISTICS 
 In our study the mean age in OSCC cases was 52.5 ± 14 years.   Mishra et al55, 
studied 66 cases of OSCC and reported the mean age in their study group as 52.9 ± 10.8 
years. In the study done by Nakayama et al51, the mean age was 70.2 years in 36 cases 
and Sawhney et al60 reported a mean age of 55 years in 107 cases of OSCC.   
 In our study, the age presentation for OSF ranged from 23 to 49 years with a 
mean of 34.3 ± 6 years which is consistent with the study done earlier at our centre by 
Ranganathan et al67.  In their study the youngest and oldest ages of occurrence of OSF 
was16 and 57 years respectively with the mean age of 32.4 ± 10.4 years. In the study by 
Kiran kumar et al68 out of the 75 cases in OSF, 50% belonged to the age group of 20 – 
29 years. 
          In our study, subjects who had OSCC were predominantly males and they 
constituted to about 80%. The male to female ratio was 4:1 and this finding was 
consistent with that of Sawhney et al60 where the male: female ratio was 3.9:1and that of 
Mishra et al55 who reported a male: female ratio of 6.3:1in patients who had OSCC.    
 In our study all the patients who had OSF were males and this finding is similar to 
a male: female ratio of 9.9: 1 reported by Ranganathan et al67 in their study of 185 OSF 
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patients at our centre earlier.  They also stated that number of males was around five 
times more than the females.    
  In this study, those patients who presented with OSCC, had the habit of chewing 
tobacco (60%) and 10% of the patient had the habit of only smoking tobacco.  This 
finding is consistent with that of Sawhney et al60 who reported that the majority of 
patients in their study (28%) had the habit of chewing tobacco whereas 20.5% patients 
had the habit of only smoking 
In this study of 20 patients who presented with OSF, 70% had the habit of 
chewing areca nut and 30% had the habit of both areca nut chewing and smoking.  These 
findings are consistent with that of Kiran kumar et al68 who reported that 81% of the 
patients had the habit of chewing areca nut.  
 
STAINING CHARACTERISTICS OF NF – κB   
 It has been shown that recurrent and persistent inflammation in the oral mucosa 
caused by continuous chewing of tobacco may induce, promote or influence 
susceptibility to carcinogenesis by causing DNA damage, inciting tissue reparative 
proliferation and creating a stromal environment enriched in cytokines and growth 
factors. NF – κB has an important role in stress response since physical, chemical 
oxidative and oncogenic stress can activate it60.  NF – κB    integrates multiple signals 
and regulates expression of multiple genes involved in different phenotypic alterations 
found in OSCC suggesting the hypothesis that NF – κB is an important molecular 
pathway for the development of cancer56.   NF- is an inducible transcription factor that 
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mediates signal transduction between cytoplasm and nucleus.  Normally, NF – κB 
presents in a latent inactive state in the cytoplasm.  Upon stimulation it is translocated in 
the nucleus58. 
 In our study, cytoplasmic expression of NF – κB   was seen in 100% cases of 
OSCC.  When we analysed the pattern of cytoplasmic staining in these OSCC cases, we 
observed that 40% of the cases showed mild intensity of staining, while 50% showed 
moderate and 10% showed intense staining. Nuclear expression of NF – κB was seen in 
30% 0f cases. The nuclear percentage positivity increased with increasing grade of 
OSCC.  
 Dysregulation of NF – κB expression and its activation is frequently observed in 
many human cancers.   Activated NF – κB shows nuclear expression and it indicates an 
early event in carcinogenesis.  Once activated, it controls the expression of several genes 
that regulate cell cycle (cyclin D1), differentiation (p21), cell survival (Bcl – 2), growth 
factors (VEGF) cell adhesion (VCAM, ECAM) and angiogenesis (MMPs).55 
  . 
 Our results were consistent with Nakayama et al51 who also reported 100% 
cytoplasmic expression in 36 cases of OSCC.  Mishra et al55 observed a 100% 
cytoplasmic expression out of which 70% showed a moderate expression and 30% 
showed weak immunoreactivity of NF – κB  .  Sawhney et al60  in their study of 107 
cases, reported cytoplasmic expression in only 68% of cases, unlike other studies where 
there was expression in 100% of the cases, but the reasoning of this finding was not 
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stated. Their study showed nuclear expression in 58% of those cases which showed 
cytoplasmic expression. 
 In the above studies there was an association between tumor progression and 
extent of nuclear translocation of NF – κB.  In our study also the moderately 
differentiated SCC exhibited increased nuclear expression which is consistent with tumor 
progression.  Nakayama et al 51 stated that high expression level of NF – κB   
contributed to the malignant behavior and anti apoptotic activity of OSCC.  Bindhu et al 
56 postulated that the increase in the nuclear Immunoreactivity could be attributed to the 
involvement of the p50-p65 hetero dimmer formation.  Mishra et al55 reported that p50 
homodynes transcriptionally regulate anti – apoptotic Bcl -2 which are over expressed in 
oral cancer cells and  thus inhibits terminal differentiation of oral keratinocyte.  The exact 
mechanism by which NF – κB is constitutively activated in OSCC is not fully 
understood, but has been suggested that the autocrine expression of IL and EGFR could 
play an important role in the activation of NF – κB   
 In inflammation associated cancer, non-genetic stimuli promote the survival and 
proliferation of cells.  NF – κB has dual actions in tumor promotion; first by preventing 
the death of the cells with malignant potential and second by stimulating the production 
of pro-inflammatory cytokines in inflammatory cells in tumor mass.  These cytokines 
then signals the cell to promote their survival and proliferation.  Classical NF – κB 
pathway i.e., the IKK – β dependent NF – κB activation pathway might show the 
molecular link between inflammation and tumor promotion48, 49.  So, in chronic 
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inflammatory diseases, pro-inflammatory factors cause accumulation of DNA damage in 
dormant pre-malignant cells in tumor microenvironment to become malignant10.   
 In our study in OSF cases, cytoplasmic expression of NF – κB was seen in 85% 
of the cases.  When we analyzed the pattern of staining, mild intensity of staining was 
observed in 40% of cases, 45% showed moderate intensity, and 5% showed intense 
cytoplasmic expression.  Our study also showed nuclear expression of NF – κB in 30% 
of cases.  When we further analyzed in order to understand the intensity of staining we 
observed that proliferating basal cells showed more expression than differentiated 
suprabasal cells.   In those cases of OSF, which showed nuclear expression, when 
examined histologically they exhibited an atrophic epithelium, with an associated 
inflammatory response in the connective tissue. Alternatively those cases of OSF, which 
did not show NF – κB expression on histological examination, exhibited minimal 
inflammation in the connective tissue. We also observed that these cases showed minimal 
fibrosis in the associated connective tissue. Recent studies suggest that NF – κB is also 
involved in the resolution of inflammation42.  During resolution, translocation of the p50-
p50   homodimers is induced.  This p50 homodimer can down-regulate anti-apoptotic gene 
expression.  This along with other co-factors can activate pro-apoptotic genes.  The pro-
inflammatory cells will receive apoptotic stimuli and will be phagocytosed by 
macrophages which have a role in resolution of inflammation10.   
 Ni W F et al53 observed intense staining of NF – κB expression in the epithelium 
of all OSF samples in their study. They also reported that intense staining was seen in 
basal and spinuous epithelial cells. 
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  Ni W F et al53 suggested that NF – κB is an important mediator in chronic 
inflammatory process.  Aberrant and persistent tissue inflammation is believed to play an 
important role on the occurrence of tissue fibrosis and cancer.  One of the etiological 
factors of OSF is area nut chewing habit.  They proposed that areca nut extract was found 
to activate NF – κB in human oral keratinocytes and one of the pathogenic mechanisms 
of OSF may be due to increased expression of NF – κB in response to areca nut.  NF – 
κB activates cytokines such as IL – 1 and TN F – α which can result in amplification of 
inflammatory, response and persistence of chronic inflammation at local site.   
  In OSF we observed nuclear staining in 30% of the cases. Thus the nuclear 
staining in our study in OSF could be attributed to the associated inflammation. In those 
cases, where nuclear expression was associated with moderate intensity of cytoplasmic 
staining, it could be suggestive of genotypic alterations due to NF – κB  activity60.  This 
can in turn lead to the expression of genes that are mediated in carcinogenesis.  Based on 
the above concept, we state that expression of nuclear staining in OSF could be used as 
an indicator for carcinogenesis. 
 In our study NF – κB staining was seen in 60% of normal cases with 10% of 
staining showing in supra basal layer.  Nuclear expression was seen in one case.  This 
finding is consistent with Mishra et al55 who reported that 20% of the normal cases 
showed positive expression.  Sawhney et al60 reported that 26% of normal cases showed 
mild cytoplasmic staining.  The nuclear expression in this study was observed in those 
normal cases which histopathologically exhibited inflammatory response.   
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 When we compared the cytoplasmic intensity and nuclear expression of NF – κB 
in OSCC and OSF we observed an increase in both the intensity and the nuclear 
Immunoreactivity but we did not observe any significant association between the two 
patterns of staining.    
 In conclusion, NF – κB expression is altered in OSCC and OSF when compared 
to normal with respect to localization and intensity, particularly in the basal layer, and has 
the potential to be used as a marker of malignant transformation. 
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• A total of 40 patients were included in the study, comprising of 10 cases of   
OSCC (group I), 20 cases of OSF (group II) and 10 patients with normal oral 
mucosa (group III). 
• In OSCC, there was 100% positivity of NF – κB staining; with 70% of 
cytoplasmic expression and 30% of nuclear expression.  Moderate to intense 
cytoplasmic expression was seen in suprabasal layer. 
• In OSF; there was 85% positivity of NF – κB expression; with 55% of 
cytoplasmic expression and 30% of nuclear staining. 
• Comparison of intensity of staining between the basal and suprabasal layer within 
the epithelium in OSF was statistically significant.  
• In normal mucosa, there was 60% of positivity of NF – κB expression within 
50% of cytoplasmic expression and 10% of nuclear expression.  Comparison of 
intensity of staining between basal and suprabasal layer within epithelium of 
normal mucosa was statistically significant  
• There was no statistically significant difference in the epithelial staining intensity 
between OSF & OSCC, OSF and normal, and also between OSCC and normal. 
• Nuclear expression of NF – κB when compared between the groups was not 
statistically significant. 
 
In conclusion our result showed that there is increased expression of NF – κB in 
OSCC and OSF when compared to normal.  Although staining intensity and mean 
labeling index did not show any significant difference between OSCC and OSF, further 
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studies on a larger sample will help in ascertaining the significance of NF – κB 
expression in OSF samples. 
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ABBREVIATIONS USED 
 
 
 
 
 
1. RHD – Rel Homology Domain 
2. IκB – Inhibitor of NF-κB 
3. IKK – IκB Kinase 
4. NEMO - NF-Κb Essential Modulator 
5. NIK - NF-Κb Inducing Kinase 
6. VCAM – Vascular Cell Adhesion Molecule 
7. ICAM – Intercellular Cell Adhesion Molecule 
8. TRAF – TNF – Receptor Associated Factor 
9. IAP – Inhibitor of Apoptosis Protein 
10. JNK – Jun N-terminal Kinase 
11. TNF – Tumor Necrosis Factor 
12. IL – Interleukins 
13. COX – Cyclo oxygenase 
14. iNOS – Inducible Nitric Oxide Synthase 
15. MMP – Matrix Metallo Proteinase 
16. uPA – Serine protease urokinas –type plasminogen activator 
 
 TABLE 1: AGE OF THE SUBJECTS IN THE STUDY GROUPS 
AGE 
Group I  Group II  Group III 
p 
value 
n  %  N  %  n  % 
0.000 
<30  0  0  5  25  7  70 
31‐40  2  20  11  55  2  20 
41‐50  3  30  4  20  1  10 
>50  5  50  0  0  0  0 
p value < 0.05 was considered to be statistically significant 
GRAPH 1: AGE OF THE SUBJECTS IN THE STUDY GROUPS 
 
GROUP I – OSCC 
GROUP II- OSF 
GROUP III – NORMAL 
 
 
 TABLE 2: DISTRIBUTION OF GENDER IN THE STUDY GROUPS 
 
CASES 
MALE  FEMALE  p value 
n  %  n  % 
0.046 
Group I  8  80  2  20 
Group II  20  100  0  0 
Group III  7  70  3  30 
p value < 0.05 was considered to be statistically significant 
GRAPH 2: DISTRIBUTION OF GENDER IN THE STUDY GROUPS 
 
GROUP I – OSCC 
GROUP II- OSF 
GROUP III – NORMAL 
 
 TABLE 3: DISTRIBUTION OF HABITS IN THE STUDY GROUPS 
Habits 
 
Group I  Group II  p value 
n  %  n  % 
0.000 
Chewing  6  60  17  85 
Smoking  1  10  0  0 
Smoking + 
chewing 
0  0  3  15 
no habits  3  30  0  0 
p value < 0.05 was considered to be statistically significant 
GRAPH 3: DISTRIBUTION OF HABITS IN THE STUDY GROUPS 
 
 
GROUP I – OSCC 
GROUP II- OSF 
 
  
 
 
TABLE 4: LOCALISATION OF NF – κB STAINING AMONG THE GROUPS 
 
 
GROUP I 
(%) 
GROUP II 
(%) 
GROUP III 
(%) 
NUCLEAR 30 30 10 
CYTOPLASMIC 70 55 50 
 
 
 
 
 
                   
                    
 
 
 
GROUP I – OSCC 
GROUP II- OSF 
GROUP III – NORMAL 
GRAPH 4: LOCALISATION OF NF – κB STAINING AMONG THE GROUPS 
 
 TABLE 5: DISTRIBUTION OF STAINING INTENSITY IN THE BASAL LAYER AMONG 
THE GROUPS 
Intensity 
Group I Group II Group III         p value 
N % n % n % 
 
0.058 
no Stain 1 10 3 15 4 40 
Mild 4 40 8 40 3 30 
Moderate 4 40 6 30 3 30 
Intense 1 10 3 15 0 0 
p value < 0.05 was considered to be statistically significant 
GRAPH 5: DISTRIBUTION OF STAINING INTENSITY IN THE BASAL LAYER AMONG 
THE GROUPS 
 
GROUP I – OSCC 
GROUP II- OSF 
GROUP III– NORMAL 
 TABLE 6: DISTRIBUTION OF STAINING INTENSITY IN THE SUPRABASAL LAYER 
AMONG THE GROUPS 
 
 
 
 
 
 
p value < 0.05 was considered to be statistically significant 
GRAPH 6: DISTRIBUTION OF STAINING INTENSITY IN THE SUPRABASAL LAYER 
AMONG THE GROUPS 
  
GROUP I – OSCC 
GROUP II- OSF 
GROUP III – NORMAL 
Intensity 
Group I Group II Group III p value 
N % N % n % 
0.28 
no Stain 0 0 4 20 4 40 
Mild 4 40 6 30 4 40 
Moderate 5 50 9 45 1 10 
Intense 1 10 1 5 1 10 
 TABLE 7: COMPARISON OF STAINING INTENSITY IN THE BASAL LAYER BETWEEN 
GROUP II AND GROUP III 
 
 
 
 
No stain 
(%) 
Mild 
(%) 
Moderate 
(%) 
Intense 
(%) p value 
Group II 15 40 30 15 
0.325 
Group III 40 30 30 0 
    
 
p value < 0.05 was considered to be statistically significant 
 
 
GRAPH 7: COMPARISON OF STAINING INTENSITY BETWEEN GROUP II AND  
GROUP III 
 
                         
 
 
GROUP II- OSF 
GROUP III – NORMAL 
 
 TABLE 8: COMPARISON OF STAINING INTENSITY IN THE SUPRABASAL LAYER 
BETWEEN GROUP II AND GROUP III 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
p value < 0.05 was considered to be statistically significant 
GRAPH 8: COMPARISON OF STAINING INTENSITY IN THE SUPRABASAL LAYER  
BETWEEN GROUP II AND GROUP III 
 
 
                    
                 
 
 
GROUP II- OSF 
GROUP III – NORMAL 
 
 
 
 
No stain 
(%) 
Mild 
(%) 
Moderate 
(%) 
Intense 
(%) P value 
Group II 20 30 45 5 
0.272 
Group III 40 40 10 10 
 TABLE 9: COMPARISON OF STAINING INTENSITY IN SUPRABASAL LAYER 
BETWEEN GROUP I AND GROUP III 
 
 
 
 
 
No stain 
(%) 
Mild 
(%) 
Moderate 
(%) 
Intense 
(%) p value 
Group I 0 40 50 10 
0.083 
Group III 40 40 10 10 
 
p value < 0.05 was considered to be statistically significant 
 
GRAPH 9: COMPARISON OF STAINING INTENSITY IN SUPRABASAL LAYER 
BETWEEN GROUP I AND GROUP III 
 
 
                   
 
 
GROUP I- OSCC 
GROUP III – NORMAL 
 
  
TABLE 10: COMPARISON OF STAINING INTENSITY WITHIN EPITHELIUM IN  
GROUP II 
 
 
 
 
No stain in 
Supra basal 
layer 
(%) 
Mild staining 
in suprabasal 
layer 
(%) 
Moderate 
stain in 
suprabasal 
layer 
(%) 
Intense 
stain in 
suprabasal 
Layer 
(%) 
Pvalue 
No stain in 
Basal layer 100 0 0 0 
0.00 Mild staining in Basal layer 0 75 0 0 
Moderate stain 
in basal layer 0 25 100 100 
 
 
p value < 0.05 was considered to be statistically significant 
 
 
 
GRAPH 10: COMPARISON OF STAINING INTENSITY WITHIN EPITHELIUM IN  
GROUP II 
 
 
 
                        
  
 
TABLE 11: COMPARISON OF STAINING INTENSITY WITHIN EPITHELIUM IN  
GROUP III 
 
 
 
 
No stain 
in Supra 
basal 
layer 
(%) 
Mild 
staining in 
suprabasal 
layer 
(%) 
Moderate 
stain in 
suprabasal 
layer 
(%) 
Intense 
stain in 
suprabasal 
Layer 
(%) 
p value 
No stain in Basal 
layer 75 0 0 0 
0.02 
Mild staining in 
Basal layer 25 100 11.1 0 
Moderate stain in 
basal layer 0 0 66.7 0 
Intense stain in 
Basal Layer 0 0 22.2 100 
p value < 0.05 was considered to be statistically significant 
 
 
 
 
GRAPH 11: COMPARISON OF STAINING INTENSITY WITHIN EPITHELIUM IN  
GROUP III 
 
 
  
Figure 1: Armamentarium 
 
 
 
 
Figure 2: Antibodies 
 
                     
 
                
               Figure 3: Oral Squamous Cell Carcinoma 
 
                  
                   
 
 
 
Figure 4: Oral Submucous Fibrosis 
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